
TNIK Therapeutics
Israel
Established in 2018
1-10 employees
Metallurgy, Chemicals, Rubber & Plastics
Sector / Industry
Metallurgy, Chemicals, Rubber & Plastics
Company description
TNIK Therapeutics targets cancer stem cell diseases by developing small molecule inhibitors of TNIK, the most downstream transcription regulator of the Wnt pathway, which is a major force driving colorectal carcinogenesis when over-activated. Targetin...
Products and services
Metallurgy, Chemicals, Rubber & Plastics
PharmaceuticalsHS 30
Promotional material
To view this content
Sign in